Trial Profile
A study of repeated mucosal patch technique (MPT) measurements and mesalazine treatment on a mucosal inflammatory marker in patients with irritable bowel syndrome (IBS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Irritable bowel syndrome
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2015 New trial record